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Autoimmune diseases and other inflammatory conditions are characterized by large
lymphocytic tissue infiltrates in which T and B cells can be found in close contact. Here, using
a murine airway inflammation model, we compare antigen-specific T and B cells in lung tissue
versus lung-draining lymph node. In the lung we identify a B-cell population exhibiting a
classical germinal centre phenotype without being organized into ectopic lymphoid tissue. By
contrast, classical CXCR5þ Bcl-6þ T follicular helper cells are not present. Nevertheless,
lung-infiltrating T cells exhibit follicular helper-like properties including the potential to
provide help to naive B cells. The lung tissue is also a survival niche for memory T and B cells
remaining in residual peribronchial infiltrates after resolution of inflammation. Collectively,
this study shows the importance of T/B cooperation not only in lymph nodes but also in
inflamed peripheral tissues for local antibody responses to infection and autoimmunity.
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L
eukocytic infiltrates in peripheral tissues are frequently
found in autoimmune conditions like rheumatoid arthritis,
systemic lupus erythematosus, Sjögren syndrome and
multiple sclerosis, but also in the lungs of asthma patients. These
infiltrates typically contain antigen-specific T and B cells, as well
as different cell populations of the innate immune system,
and contribute substantially to tissue destruction and immuno-
pathology. B cells produce (auto-) antibodies locally and also
seem to play a role as antigen-presenting cells for T lymphocytes
in the periphery. T cells in turn produce proinflammatory
cytokines, which attract tissue-destructive granulocytes and also
affect non-lymphoid cells, for example, goblet cells to produce
mucus in the case of airway inflammation. However, an often
neglected function of T cells in inflamed tissues is their potential
to provide help to antigen-specific B cells.
This helper function of T cells is the major role of T follicular
helper (TFH) cells, a specialized population of T cells in
secondary lymphoid organs (SLOs)1. This T-cell population is
crucial for B-cell maturation and differentiation in the germinal
centre (GC) response2. Without TFH cells, no affinity-matured
long-lived plasma cells and memory B cells are generated. These
two terminally differentiated B-cell populations are the basis for
protective immunity; however, they can pose a major problem
when producing autoreactive antibodies. Therefore, TFH cells are
an attractive target for the treatment of autoimmune and other
inflammatory diseases.
Under certain conditions, SLO-like structures can develop in
inflamed tissues. They are known as ‘ectopic lymphoid tissue’ or
as ‘induced bronchus-associated lymphoid tissue’ in the lungs3,4.
Ectopic lymphoid tissues represent highly ordered structures with
separate T- and B-cell zones. Another important characteristic is
the presence of follicular dendritic cells (FDCs) similar to follicles
in SLO. Ectopic lymphoid tissues exhibit many features of SLO,
including formation of germinal centres in which T and B cells
cooperate5.
However, the development of ectopic lymphoid tissue in
inflamed tissues is an exceptional case, which requires experi-
mental settings with strong stimuli or other facilitators like a viral
infection3. In human autoimmune conditions, fully differentiated
ectopic follicles are only rarely observed6,7. Nevertheless,
FDC-negative lymphocytic infiltrates contain T and B cells in
very close contact raising the question whether T/B cooperation
can also take place in infiltrates not exhibiting the features of
ectopic lymphoid tissue.
To analyse the cooperation of antigen-specific T and B cells in
inflamed tissues in more detail, we use a novel lung inflammation
mouse model, which makes it possible to analyse and compare
the interaction of antigen-specific T and B cell simultaneously in
inflamed lung tissue, as well as in the lung-draining lymph nodes.
With this model we identify the inflamed lung tissue as the major
reservoir of antigen-specific T and B cells. The lung tissue does
not only contain antigen-specific plasma cells but also a
population of GC-like B cells. In contrast, no classical CXCR5þ
Bcl-6þ TFH cells are present in the lung. However, we identify a
population of lung-infiltrating helper T cells, which seem to take
over the functions of TFH cells. Finally, we show that the lung
tissue is an important survival niche for antigen-specific memory
T and B cells, which might be important for fast local secondary
responses.
Results
Antigen-specific T and B cells accumulate in lung tissue. The
low natural frequency of antigen-specific T and B cells makes it
difficult to analyse their interaction in an inflammatory
reaction. Therefore, we developed an in vivo T/B cooperation
system, in which ovalbumin (OVA)-specific T cells were
co-transferred with nitrophenol (NP)-specific B cells into
immunocompetent recipient mice (Fig. 1a). After adoptive
transfer, recipient mice were challenged intranasally (i.n.) with an
NP–OVA conjugate as antigen and lipopolysaccharide (LPS)
as an adjuvant. This system makes it possible to analyse antigen-
specific T and B cells simultaneously in lung tissue and lung-
draining lymph nodes, using the congenic markers Thy-1.1 and
CD45.1 (in all subsequent figures, antigen-specific refers to cells
gated on either CD4þ Lin Thy-1.1þ or CD19þ Lin
CD45.2 CD45.1þ ). One to two days after antigen challenge,
antigen-specific T and B cells accumulated in the lung-draining
lymph nodes where they proliferated vigorously. Although cells
evenly distributed to all SLOs on transfer, no activated antigen-
specific T and B cells were found in non-draining organs like the
spleen. In the lungs, activated antigen-specific T and B cells
appeared around day 5 (Supplementary Fig. 1). After repeated
antigen challenges, a stable population of lung-infiltrating T and
B cells developed, which did not change much over time.
Therefore, we routinely analysed recipient mice on day 17 for
antigen-specific T and B cells in the draining lymph nodes versus
the inflamed lung. At that time, more than 80% of all antigen-
specific T and 60% of B cells were found in the lungs, identifying
the inflamed tissue as the major reservoir of antigen-specific
T and B cells (Fig. 1b).
Infiltrates harbour T and B cells in intimate contact. After
repeated i.n. challenge with antigen, we observed the typical signs
of chronic lung inflammation, such as appearance of large
lymphocytic infiltrates and airway narrowing with increased
mucus production (Fig. 2a). Immunohistological examination on
day 17 revealed large lymphocytic clusters containing eosinophils
and antigen-specific T cells located adjacent to antigen-specific B
cells. Under chronic inflammatory conditions, lymphocytic
infiltrates can develop further into ectopic lymphoid tissue,
characterized by the presence of FDC3,4. Therefore, we stained
the lung infiltrates for CD21/35 (complement receptor 2), which
is expressed on FDC at high density. More than 96% of infiltrates
were negative for CD21/35 (Fig. 2c and Supplementary Fig. 2).
Only some very large infiltrates located near the central bronchus
stained positive for FDC markers (Fig. 2b and Supplementary
Fig. 2). In contrast to the FDC-negative infiltrates composed of
loose aggregates of T and B cells, these CD21/35-positive
infiltrates showed highly organized separate T- and B-cell zones
(Fig. 2b, lower panel). It is well established that T/B cooperation
can take place in these SLO-like structures3,4. However, the close
contact of antigen-specific T and B cells in the predominating
FDC-negative loose aggregates raised the question whether local
T/B cooperation might take place there as well.
Lung tissue contains B cells with a GC-like phenotype. To find
indications for T/B cooperation in the inflamed tissue, we com-
pared the phenotype of lung-infiltrating B cells with that of lymph
node B cells. First, we looked for antibody-secreting cells, which
are generated both in the extrafollicular and GC B-cell responses.
On day 17, up to 30% of antigen-specific B cells in the draining
lymph nodes expressed CD138 and had downregulated CD19, a
characteristic feature of plasma cells (Fig. 3a). The lung tissue
contained a very similar fraction of antigen-specific plasma cells.
However, when considering the higher absolute numbers of
antigen-specific B cells (compare Fig. 1b), the lung tissue turned
out to contain eight times more plasma cells than the lung-
draining lymph node. Intracellular staining of immunoglobulin
subclasses revealed that antigen-specific plasma cells from both
sites were mainly switched towards IgG1 and IgA, with few cells
producing IgG2a and IgE (Supplementary Fig. 3). Histological
analysis showed that CD138-positive plasma cells were equally
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found in FDC-positive and -negative infiltrates (Supplementary
Fig. 4).
Next, we analysed the generation of GC B cells. Around 60% of
the transgenic B cells in the lymph node displayed a GC
phenotype, defined by staining with peanut agglutinin (PNA) and
the monoclonal antibody GL7 (Fig. 3b). Looking for these
classical GC B-cell markers in the lungs, we surprisingly found a
prominent population of PNA/GL7 double-positive cells, which
only differed by a slightly reduced binding of PNA (Fig. 3b).
Although their frequency in the lung was lower, their absolute
number was similar to that in the lymph node. GC B cells have
been detected in ectopic lymphoid structures of inflamed tissues5.
However, the high percentage of PNAþ /GL7þ cells in our
inflammation model was unexpected given the fact that the vast
majority of lung infiltrates consisted of loose T/B aggregates and
not ectopic lymphoid tissue. Therefore, we analysed additional
markers that are more specific for GC B cells. The GL7þ B cells
in the lung expressed the transcription factor Bcl-6, which is a key
regulator of GC B-cell differentiation2, and had downregulated
CD38, another attribute of GC B cells8. Moreover, PNA/GL7
double-positive cells in lymph node and lung expressed the
activation-induced cytidine deaminase, which is involved in
somatic hypermutation of GC B cells (Fig. 3b).
To define the localization of the GC-like B cells, we analysed a
lung section near the central bronchus, which contained both
ectopic lymphoid tissue and unstructured infiltrates (Fig. 3c). As
expected, some GL7þ GC B cells were present in ectopic
lymphoid tissue containing CD21/35þ FDC. However, most
GL7þ B cells were found in infiltrates without FDC, demonstrat-
ing that GC-like B cells can exist outside GC structures (Fig. 3c).
This explains how up to 40% of lung-infiltrating B cells displayed
a GC phenotype although 96% of all lung infiltrates in our model
were composed of loose T/B aggregates. Staining for the cell cycle
marker Ki-67 revealed that B cells within these infiltrates were
highly proliferating (Fig. 3d). This further indicates that active
T/B cooperation takes place within these loose lung infiltrates.
Finally, we sequenced the transgenic B-cell receptor heavy
chain from FDC-positive and -negative infiltrates obtained by
laser microdissection. Both types of infiltrates contained hyper-
mutated B cells. The ratio of replacement versus silent mutations
(1.24 versus 1.33) and also the percentage of clones with the
affinity-determining tryptophan to leucine mutation at codon 33
(60% versus 52%) were similar in FDC-positive and -negative
infiltrates.
Taken together, our data show that B cells in lymph nodes and
lung are similar in their phenotype. However, in contrast to
lymph nodes, where PNAþ /GL7þ cells are present only in GC,
we identified GC-like B cells outside of ectopic lymphoid
structures in inflamed lung tissue.
Lung-infiltrating T cells are no classical TFH cells. As the
generation of GC B cells in lymph nodes critically depends on the
presence of TFH cells, we analysed the proportion of transgenic
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Figure 1 | Inflamed lung tissue is the major reservoir of antigen-specific T and B cells. (a) General set-up for the airway inflammation model.
Preactivated OT-II T cells and naive B1-8i/kappa light chain knockout B cells were transferred into syngeneic C57BL/6 mice. OT-II cells express a T-cell
receptor specific for OVA, B1-8i cells have a knock-in for the germline VH186 heavy chain, which recognizes the hapten NP in combination with any lambda
1 light chain31. On the indicated days, recipient mice were immunized i.n. with an NP–OVA conjugate and LPS. Cells from lungs and lung-draining lymph
nodes were typically analysed on day 17 when airway inflammation was fully established. Antigen-specific T and B cells were identified by flow cytometry
using the congenic markers Thy-1.1 and CD45.1, respectively. (b) Total numbers of antigen-specific T and B cells in lung-draining lymph node (Ln) and lung
tissue on day 17. Shown are absolute cell numbers of a representative experiment and the ratio of antigen-specific T and B cells in lymph node versus lung
(pooled data from 6 experiments with 34 animals). Error bars show s.e.m. ***Po0.001 by Mann–Witney U-test.
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lung-draining lymph nodes about 40% of T cells displayed a TFH
phenotype (Fig. 4a). In contrast, this population was missing
completely in the inflamed lung tissue. Interestingly, only CXCR5
was absent on lung T cells, whereas PD-1 was equally expressed
on lung as well as on lymph node T cells (Fig. 4b). To define TFH
cells more precisely we stained their master transcription factor
Bcl-6. As expected, antigen-specific CXCR5 PD-1 T cells in
the lymph node were negative for Bcl-6, whereas a significant
Bcl-6 expression was found in the CXCR5þ PD-1þ subset.
In contrast, lung-infiltrating T cells did not express Bcl-6 at all
(Fig. 4a, right panel).
To further compare lung-infiltrating and lymph node T cells,
we analysed additional markers that are typically expressed by
TFH cells: the chemokine receptor CCR7, which is also involved
in the positioning of TFH cells in the B-cell zones of SLO,
and CD40L and ICOS, which are important effector molecules.
Interestingly, lung-infiltrating T cells had downregulated CCR7 to
an even stronger extent than antigen-specific T cells in the lymph
node (Fig. 4b). At the same time, expression levels of CD40L and
ICOS were higher on lung-infiltrating T cells compared with
lymph node T cells.
T-cell help to B cells is mediated by CD40L and secretion of
interleukin (IL)-4 and IL-21. To assess the cytokine-producing
potential of lung-infiltrating and lymph node T cells, these cell
populations were re-stimulated with antigen in vitro. IL-4 and
IL-21 were the two dominating cytokines, produced by more than
20% of antigen-specific T cells (Fig. 4c). While IL-4 was produced
to a similar amount by lymph node and lung T cells, IL-21
production by lung-infiltrating T cells was in all experiments
significantly higher than by antigen-specific T cells isolated from
the draining lymph nodes. Interestingly, expression of additional
effector cytokines such as IL-5, IL-10, IL-13, IL-17 and interferon
(IFN)-g was largely confined to lung T cells with an at least
threefold higher expression than antigen-specific T cells from the
draining lymph nodes. The higher expression of Th2 effector
cytokines by lung T cells was associated with a significantly
increased expression of the master transcription factor GATA-3
(Fig. 4d).
In contrast to the classical TFH cells in the lymph node, there
was no cell surface marker on lung-infiltrating T cells identifying
a subset with particular B helper capacity. Therefore, we analysed
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Figure 2 | Lung infiltrates contain antigen-specific T and B cells in close contact. (a) Cryosections from non-inflamed and inflamed lung tissues (day 17)
were stained with haematoxylin to visualize cellular infiltrates. The images on the right show serial sections of the highlighted perivascular infiltrate or the
nearby bronchus in higher magnification. Immunostaining (red) for OVA-specific T cells, NP-specific B cells and eosinophils was performed using the
indicated markers. Production of mucus was visualized by periodic acid–Schiff staining. Scales bars, 200mm for the low-resolution images (original
magnification  5) and 50mm for the high-resolution images (original magnification  20). (b) Ectopic lymphoid tissue was identified by staining of serial
cryosections for FDC and antigen-specific T and B cells using the indicated markers. Scale bars, 100 mm for the low-resolution images and 20mm for the
high-resolution image (original magnification  20). Images are representative of 2–4 independent experiments with 10–18 animals total. (c) Area of
FDC-containing regions as percentage of total infiltrate area, quantified as shown in Supplementary Fig. 2. Each dot represents data from a single
pulmonary lobe.
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cytokine for lung effector T cells. IL-4-, IL-10-, IL-13- and IFN-g-
producing cells were highly enriched in the IL-21-positive
compared with the IL-21-negative subset (Supplementary
Fig. 5). As a second cytokine, the IL-21/IL-4 double-positive
versus the IL-21þ IL-4 subset demarcated cells with highest
expression of IL-10 and IL-13.
To demonstrate that the B helper potential of lung-infiltrating
T cells was not a consequence of the preactivation of OT-II T
cells under Th2-polarizing conditions, we ran our airway
inflammation model also with the transfer of naive T cells.
Under these conditions, all previous observations could be
reproduced (Supplementary Fig. 6). We found a GC-like B-cell
population in the lung but no CXCR5þ TFH cells. The cytokine
profile partly changed with almost no IL-4- and IL-13-producing
cells. Instead, a population of up to 30% IL-17-producing cells
was generated in the lung, which is a typical reaction for antigens
taken up via an intranasal route9. Importantly, production of
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Figure 3 | Similar phenotype of B cells in lymph node and lung tissue. Flow cytometric analysis (day 17) of antigen-specific (CD45.1þ ) B cells from
lung-draining lymph nodes and lung tissue. (a) Comparison of plasma cells, defined as CD19low CD138þ , from lymph nodes and lungs. Shown are flow
cytometric plots, and the frequency and absolute numbers of NP-specific B cells with a plasma cell phenotype from a representative experiment and the
ratio of plasma cells in lung-draining lymph nodes as pooled data from 3 experiments with 20 animals total. (b) Comparison of GC/GC-like B cells from
lymph nodes (Ln) and lung tissue. Frequency and absolute numbers from a representative experiment, and relative distribution of GL7þ PNAþ B cells
between lymph node and lung as pooled data from 4 experiments with 26 animals. For further characterization, cells were co-stained for CD38 and
intracellular Bcl-6 or activation-induced cytidine deaminase (AID). CD38 expression is shown as histograms on GL7/Bcl-6 double-negative (black) versus
double-positive (orange) cells. AID expression is shown on GL7/PNA-positive (red line) and -negative (black line) cells relative to an isotype control (filled
grey histogram; concatenated flow cytometry data from five animals). (c) Staining of lung tissue containing ectopic lymphoid tissue defined by the presence
of FDC (CD21/35þ , yellow) and a greater number of unstructured infiltrates. Staining with the GC B-cell marker GL7 is shown in magenta. (d) Co-staining
of transgenic B cells (magenta) and the cell proliferation marker Ki-67 (yellow) in an FDC-negative infiltrate. Scale bars, 100mm, original magnification
 20. Data are representative for at least two independent experiments. Error bars show s.e.m. NS, not significant: PZ0.05, *Po0.05, **Po0.01 by
Mann–Witney U-test.
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IL-21 turned out to be a lead cytokine for lung T cells, with higher
IL-17 and IFN-g production in the IL-21-positive versus
-negative subset.
Collectively, in striking contrast to the presence of GC-like B
cells in the lung, no classical CXCR5þ Bcl-6þ TFH cells could be
found. However, regarding other markers, lung-infiltrating T cells
shared many similarities with TFH cells and had a high B helper
potential by expressing CD40L, IL-4 and especially IL-21.
Lung-infiltrating T cells produced additional effector cytokines
like IL-5, which functions not only as a chemoattractant for
eosinophils but is also important for the class-switch of B cells
towards IgA10.
Lung-infiltrating T cells provide help for B cells. To function-
ally test their capacity for B-cell help, antigen-specific
T cells from lung-draining lymph nodes or lung tissue were
sorted and co-cultured with naive NP-specific B cells in the
presence of cognate antigen. After 7 days, B cells co-cultured with
lung T cells had produced large amounts of IgG1, although not
quite to the extent as B cells co-cultured with T cells from lymph
nodes (Fig. 5a, upper panel). However, production of IgA was
similarly high in both groups (Fig. 5a, lower panel). Moreover,
lung T cells induced the ligands for GL7 and PNA, and the
activation marker CD69 on the co-cultured B cells to the same
extent as lymph node T cells (Fig. 5b). Taken together,
lung-infiltrating T cells are fully capable to provide B-cell help,
although they lack the prototypic TFH cell markers CXCR5
and Bcl-6.
The lung is a major reservoir for memory B cells. After looking
at T/B cooperation during the effector phase of airway inflam-
mation, we analysed antigen-specific T and B cells during the
memory phase. Even as late as day 41, 4 weeks after last antigen
application, perivascular lymphocytic infiltrates could still be
found in the lung (Fig. 6a). These infiltrates contained substantial
numbers of antigen-specific B cells. At the same time, barely any
NP-specific B cells were detectable in the lymph node (Fig. 6b). In
contrast to the effector phase, where activated antigen-specific
cells were exclusively found in the lung and lung-draining lymph
node, memory B cells were now also present in spleen and bone
marrow. While the highest frequency of memory B cells was
found in the lung, the majority of memory B cells in absolute
numbers resided in the spleen taking into account the higher
cellularity of this organ (Fig. 6b).
We analysed additional markers to characterize these lung-
resident antigen-specific B cells. While during the effector phase
almost all antigen-specific B cells in the lungs displayed either a
GC or plasma cell phenotype, CD138þ , intracellular Igþ or
GL7þ , PNAþ and CD38low cells were no longer present at this
late time (Fig. 6c and Supplementary Fig. 7). Half of the antigen-
specific B cells in the lungs expressed surface IgM, whereas the
others were class-switched towards either IgG1 or IgA (Fig. 6c).
Around 40% of all B cells expressed CD80, which is regarded as a
marker for highly mutated memory B cells11. In addition, we
analysed the expression of PD-L2 and CD73, which are also
expressed by subsets of memory B cells12. Altogether, more than
85% of the B cells expressed PD-L2, CD73 or CD80, and can
therefore be regarded as typical memory B cells, identifying the
lung as an important niche for antigen-specific memory B cells.
Since o10% of the antigen-specific B cell numbers found
during the effector phase remained at day 41, we had to take into
account the possibility that they might be exclusively located in
the FDC-positive infiltrates near the central bronchus. However,
like in the effector phase, the vast majority of infiltrates were
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Figure 4 | Lung tissue does not contain classical TFH cells. Comparison
of antigen-specific (Thy-1.1þ ) T cells from lymph nodes (Ln) and lung
tissue. (a) Analysis of CXCR5/PD-1 expression. The right panel shows
intracellular staining for Bcl-6 in lymph node TFH cells (CXCR5þ/PD-1þ )
and non-TFH cells (CXCR5/PD-1 ), and in the whole population of
lung-infiltrating T cells. The inset numbers indicate the mean fluorescence
intensity (MFI)± s.e.m. (b) Expression of PD-1, CCR7, CD40L (intracellular
staining, no restimulation) and ICOS on lymph node (grey-filled
histograms) versus lung-infiltrating (black open histograms) T cells. (c)
Intracellular staining for IL-4, IL-5, IL-10, IL-13, IL-21 and IFN-g after short-
term restimulation with OVA peptide in vitro. A representative staining from
lung-infiltrating T cells is shown for all cytokines. (d) Intracellular staining
for GATA-3 comparing the MFI between lymph node and lung T cells
(dotted line¼GATA-3 staining on non-antigen-specific (endogenous)
lymph node CD4þ T cells). Data are representative of 3–4 independent
experiments with 7–9 animals per experiment. NS, not significant: PZ0.05,
*Po0.05, **Po0.01, ***Po0.001 by Mann–Witney U-test.
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also in the memory phase the great majority of antigen-specific B
cells resided in FDC-negative infiltrates (Fig. 6d).
Memory T and B cells are in close contact in the lung. To
additionally analyse antigen-specific memory T cells, we switched
our system to the adoptive transfer of Smarta T-cell receptor-
transgenic instead of OT-II T cells, which allows for long-term
tracking in vivo13 (Fig. 7a). We co-stained lung sections for
antigen-specific T and B cells on day 64 (47 days after the last
antigen challenge). Like in the effector phase (compare Fig. 2a)
both cell types were still found in close contact within the residual
infiltrates (Fig. 7b). Antigen-specific memory T cells were
recovered not only from lung tissue but also from lung-
draining lymph node, spleen and bone marrow (Fig. 7c).
Consistent with the distribution of the memory B cells, the
highest frequency of memory T cells was found in the lung,
however, the highest absolute number was in the spleen.
Discussion
The interaction of T and B cells in SLO as well as in ectopic
lymphoid tissue, which are structurally and functionally similar,
has been investigated in great detail in the past. However, it is still
unclear whether T/B cooperation can also take place in unordered
T/B infiltrates lacking the characteristics of SLO, such as clearly
separated T- and B-cell zones and the presence of FDC. This
question is of major interest, because these unstructured T/B
aggregates represent the vast majority of infiltrates in inflamed
tissues in autoimmune and allergic diseases. While early studies
reported the presence of FDC-positive ectopic lymphoid tissue in
around 25% of all synovial biopsies from rheumatoid arthritis
patients14, a more recent study found fully differentiated follicles
in only 6% of the biopsies6. The predominant type of infiltrates
was characterized as either diffuse T- and B-cell infiltrates or T/B
aggregates lacking FDC structures. Similar observations were
made in studies analysing T/B infiltrates in kidneys of systemic
lupus erythematosus patients7,15.
To study T/B cooperation in inflamed tissues, we
complemented the well-established murine airway inflammation
model based on the adoptive transfer of OVA-specific T cells16 by
an additional transfer of antigen-specific B cells. This novel
airway inflammation model allowed us the parallel analysis of
antigen-specific T and B cells during early and late phases of the
immune response, thus providing new insights into the
phenotype and function of T and B cells in peripheral inflamed
tissues. The adoptive transfer system enabled us to track
antigen-specific T and B cells, and showed that in the chronic
phase of the immune response the vast majority of antigen-
specific T and B cells were not located in the draining lymph
nodes but in the inflamed tissue. Similar to the situation in
autoimmune patients, T/B infiltrates in the lung mainly consisted
of loose aggregates lacking FDC and any ordered structures.
Nevertheless, not only plasma cells but also GC-like B cells
were found in these infiltrates. This shows that SLO-like
structures and FDC are not absolutely necessary for the
development of GC-like B cells. So far, this only has been
shown for the very special case of the so called milky spots in the
omentum17. These structures, important for peritoneal cavity
immune responses, completely lack FDC but develop GC B cells
on antigen exposure.
Despite the presence of GC-like B cells, no classical TFH cells
expressing CXCR5 and Bcl-6 were found in the inflamed lung
tissue. Three recent publications demonstrated the presence of
CXCR5-positive TFH cells in inflamed lung tissue. However, in
one study CXCR5þ T cells were directly shown to reside in
ectopic lymphoid structures18; in the other two studies19,20 this
aspect was not analysed, but both used infection models, where
the development of ectopic lymphoid tissue can be presumed.
We, however, focused on antigen-specific T cells in loose
lymphocytic aggregates, and not in ectopic lymphoid tissue.
These lung-infiltrating T cells lacked classical TFH cell markers,
but still had potent B-cell helper capacities and were present in
close contact with strongly proliferating GC-like B cells.
Lung T cells





























































Figure 5 | Lung-infiltrating T cells provide B-cell help. Sorted antigen-specific (Thy-1.1þ ) effector T cells (day 17) from lungs or lymph nodes (Ln), or
naive OT-II cells were co-cultured with naive NP-specific B cells in the presence of NP–OVA for 7 days. Thereafter, (a) NP-specific IgG1 and IgA were
measured by ELISA and (b) B cells were stained with PNA, GL7 or anti-CD69, and analysed by flow cytometry. Shown are representative results from three
independent experiments with six replicates each. Error bars show s.e.m. NS, not significant: PZ0.05, **Po0.01 by Mann–Witney U-test.
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The high frequency of Ki-67-positive B cells indicates that active
T/B cooperation takes place. Indeed, a recent detailed clonal tree
analysis of B cells located in Ki-67þ but FDC-negative T/B
aggregates from lupus nephritis patients revealed ongoing
somatic hypermutation7. These FDC-negative T/B infiltrates in
the kidney were first described by our group15. Already in this
early study we had many indications that active T/B cooperation
takes place in the infiltrates and leads to the local generation of
plasma cells.
The CXCR5-negative B helper T cells from the lung exhibit
some features of other recently described T-cell populations with
B helper potential, such as splenic extrafollicular helper T cells
found in certain autoimmune mouse models21. Despite their
non-TFH phenotype with very low CXCR5 expression, these
extrafollicular T cells exhibited a strong potential for B-cell help
through expression of IL-4, IL-21 and CD40L, and might be
important for the extrafollicular plasma cell reaction. The second
example is bone marrow-resident CD4þ memory T cells that
also lack typical TFH features22, but are, nevertheless, capable of
providing help to B cells for antibody production and affinity
maturation. In the rheumatoid joint CXCR5- and Bcl-6-negative
T cells were shown to be a source of CXCL13, which might be
important for the recruitment of B cells23. A very recent
publication described CXCR5-negative but IL-21-positive
T cells in the inflamed lung24.
So why are lung-infiltrating B helper T cells negative for
CXCR5? Possibly, because they simply do not need this
chemokine receptor to get into contact with B cells. In the
unordered infiltrates with interspersed T and B cells as observed
in our model, T cells do not have to migrate from a T-cell area
into a B-cell follicle as in the lymph node. In addition, expression
of the CXCR5 ligand CXCL13 is unlikely in these FDC-negative
lung infiltrates, since in the mouse this chemokine is mainly
produced by FDC25.
Our study did not only identify the lung tissue as a major
reservoir for antigen-specific effector cells but also as a niche for
long-lived memory B cells. Tissue-resident memory T cells were
recently recognized as a discrete memory T-cell subset, which
facilitates rapid secondary responses directly at the site of antigen
entry26. Our study now shows that not only antigen-specific T but
also B cells are found in close contact in the lung tissue. So far,
only three studies described the presence of memory B cells in the
lung27–29, and all were viral infection models, which (different
to our model) typically include the development of ectopic
lymphoid tissue. The persisting T/B infiltrates in the lung might
be important in secondary immune responses for the rapid
generation of antigen-specific plasma cells directly at the site of
antigen entry. Interestingly, antigen-specific memory T and B
cells additionally distributed to other classical memory cell niches











































































































Figure 6 | Lung tissue is a major reservoir for antigen-specific memory B cells. Analysis of lung-resident B cells 28 days after the last antigen challenge
(day 41). (a) Histological analysis of lung tissue showing a peribronchial infiltrate. Antigen-specific B cells (CD45.1þ , green) were preferentially found in
the proximity of vessels. Br, bronchus, V, vessels. Scale bar, 50mm, original magnification was  20. (b) Frequencies and absolute numbers of antigen-
specific (CD45.1þ ) B cells isolated from lymph node (Ln), lung, spleen (Spl) and bone marrow (Bm) on day 41. (c) Characterization of lung-resident
antigen-specific B cells showing representative staining for CD38, IgM, IgG1, IgA and the memory markers PD-L2, CD80 and CD73. Representative data
from two independent experiments with six mice per experiment are shown. (d) Co-staining of antigen-specific B cells (CD45.1) and FDC (CD21/35) in
lung tissue on day 42. Scale bars, 500mm in the overview and 100 mm in the detail enlargement.
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the lung can give rise not only to local but also systemic
protection.
Our detailed analysis of T/B cooperation in inflamed tissues is
also highly relevant from a clinical perspective. With improved
therapeutic options for autoimmune diseases preventing long
phases of chronic disease, the development of ectopic lymphoid
tissue as a final stage of tissue infiltration is nowadays only rarely
observed. However, FDC-negative, unstructured lymphocytic
tissue infiltrates are a frequent pathological finding, and our
study shed more light on the interaction of autoreactive T and B
cells in these infiltrates.
Methods
Mice. OT-II (Jax stock 004194) and Smarta30 T-cell receptor transgenic mice or
B1-8i mice31 (additionally crossed with kappa light chain knockout mice32 to
ensure NP-specificity of B cells) were crossed to B6PL (Thy-1.1þ , Jax stock
000406) or Ly-5.1 (CD45.1þ , Jax stock 002014) mice, respectively. Transgenic
strains and wild-type C57BL/6 mice were bred under specific pathogen-free
conditions in the animal facility of the Federal Institute for Risk Assessment, Berlin.
For experiments female mice in an age between 8 and 16 weeks were used. Animal
experiments were conducted according to the German animal protection laws, and
approved by the responsible governmental authority (LAGeSo).
Airway inflammation model. OT-II T cells from spleens were sorted magnetically
for CD62Lhigh cells (Miltenyi Biotec), and cultured with splenocytes for 5 days with
the addition of OVA peptide, recombinant IL-4, anti-IFN-g and anti-IL-12. 2 106
OT-II T and 2 106 B1-8i B cells were adoptively transferred into C57BL/6 mice
by intravenous injection, 16–24 h later mice were challenged i.n. with 5 mg
NP-OVA conjugate and 5 mg LPS (Sigma) as adjuvant. Challenge with same
amounts of antigen was repeated on day 1, 10 and 13. For analysis of memory
T cells, naive T cells from Smarta mice were directly co-transferred into recipients.
Mice were challenged i.n. with NP and the cognate peptide (P13 GP61–80)
chemically coupled to mouse serum albumin (20 mg on day 0 and 1, and 5 mg on
days 10, 13 and 17) and 5 mg LPS.
Cell isolation. Lungs were perfused with PBS. Bronchial lymph nodes were
dissected from the lung tissue under a microscope and prepared separately for flow
cytometric analysis by meshing through a 70-mm sieve. Single-cell suspensions
from lung tissue were prepared using the gentle MACS dissociator (Miltenyi
Biotec) and digestion with 0.5 mg ml 1 collagenase D and 20 mg ml 1 DNase I
(Roche) for 25 min at 37 C. Spleens were meshed through a sieve, and bone
marrow was flushed out of femur and tibia of hind legs. All cells were counted
using a Guava EasyCyte capillary flow cytometer and ViaCount solution
(Millipore).
T/B co-cultures. To compare the B-cell helper qualities of effector T cells from
lymph nodes and lung, cells from both organs were enriched with anti-Thy-1.1
microbeads (Miltenyi Biotec) followed by flow-sorting on a FACS ARIA II
(BD Biosciences) for CD4þ Thy-1.1þ Thy-1.2 CD44high CD8 B220
DAPI cells. Naive T cells from spleens of OT-II mice were sorted as CD4þ
Thy-1.1þ CD62Lþ B220 DAPI cells. Naive B cells were sorted from spleens
of B1-8i mice as CD19þ CD4 DAPI cells. T and B cells were co-cultured in
96-well round-bottom plates (4–6 individual wells) at a 1:4 ratio in the presence of
10 mg ml 1 NP–OVA for 7 days.
Flow cytometry. Single-cell suspensions from lymph node, lung, spleen or bone
marrow were stained with different combinations of fluorophore-conjugated
antibodies (Supplementary Table I). Streptavidin-PE-Cy7 (0.25 mg ml 1) or
-PerCP (0.5 mg ml 1) were used as secondary reagents for biotinylated Ab.
Fc receptors were blocked with 20 mg ml 1 2.4G2 (anti-CD16/32).
For analysis of cytokine production, cells were re-stimulated in vitro with OVA
peptide for 4.5 h with Brefeldin A added after 1 h. Following staining of cell surface
antigens, cells were fixed with formaldehyde, permeabilized with saponin and
stained intracellularly with anti-cytokine antibodies (Supplementary Table I).
For detection of IL-21, an IL-21R-Fc chimera, followed by Cy5-conjugated goat
anti-human Ig (Jackson ImmunoResearch, 1:800), was used.
For intracellular staining of transcription factors (Supplementary Table I) the
FoxP3 Staining Buffer Set from eBioscience was used. For activation-induced
cytidine deaminase staining, cells were stained intracellularly before surface
staining, and Alexa Fluor 647-conjugated goat anti-rat Ig (Invitrogen, 2.5 mg ml 1)
was used as secondary reagent. For intracellular staining of Ig, cells were fixed with
formaldehyde, permeabilized with saponin buffer and stained with fluorescein
isothiocyanate (FITC)-conjugated anti-Ig antibodies (Supplementary Table I).
To discriminate dead cells, either 4,6-diamidino-2-phenylindole (DAPI) was
added to live cells immediately before analysis or cells were stained with 1.34 mM
Pacific Orange succinimidyl ester (Invitrogen) before fixation. Samples were
analysed on an LSR II or LSR Fortessa flow cytometer (BD Biosciences). Analysis
gates were set on live cells defined by scatter characteristics and exclusion of
doublets and dead cells. In all figures, antigen-specific T cells are defined as DAPI
B220 CD4þ Thy-1.1þ and B cells as DAPI CD3/CD8 CD19þ CD45.2
CD45.1þ . Data were analysed with FlowJo Software (Treestar).
Enzyme-linked immunosorbent assay. NP-specific IgG1 and IgA was
measured by enzyme-linked immunosorbent assay. Plates were precoated with
NP-coupled BSA, and bound antibodies were detected by using horseradish
peroxidase-coupled antibodies to mouse IgG1 or IgA (Southern Biotechnologies)
and tetramethylbenzidine as substrate.
Histology. Lungs were filled with 50% TissueTek OCT compound via the trachea
and snap frozen in ice-cold isopentane. The 8-mm cryostat sections of the
right lower lobe were cut and fixed with acetone. To reduce unspecific signals,
peroxidase inactivation and blocking with Casein Solution (Vector Laboratories)
was performed.
For light microscopy, tissue section was stained with FITC-coupled OX-7
(anti-Thy-1.1, 1.25 mg ml 1), A20 (anti-CD45.1, 5 mg ml 1), 7G6 (anti-CD21/35,
1 mg ml 1), unconjugated 281-2 (anti-CD138, 5 mg ml 1) or MBP-1 (anti-MBP,
kindly provided by J. Lee, Scottsdale, 1:2,500). As secondary reagents,
peroxidase-conjugated antisera against FITC, digoxygenin (Roche, 1:300) or rat-
IgG (Jackson ImmunoResearch, 1:4,000) were used. Slides were developed using
3-amino-9-ethylcarbazole as substrate, nuclei were counterstained with
haematoxyline. A periodic acid–Schiff-staining kit (Carl Roth) was used to stain
mucopolysaccharides. Slides were analysed on an Axioskop 2 light microscope




















































Figure 7 | Clusters of antigen-specific memory T and B cells remain in the
non-inflamed lung. (a) Smarta T-cell receptor transgenic (Tg) T cells were
co-transferred with B1-8i B cells into C57BL/6 recipients. Mice were
repeatedly challenged i.n. with NP and Smarta peptide coupled to mouse
serum albumin as non-immunogenic carrier and analysed 47 days (d) after
the last challenge. (b) Histological analysis of lung tissue showing antigen-
specific T cells (Thy-1.1þ ) in yellow and B cells (CD45.1þ ) in magenta.
Scale bars, 500mm in the overview and 50mm in the detail enlargement.
(c) Frequencies and absolute numbers of antigen-specific T cells isolated
from lymph node (Ln), lung, spleen (Spl) and bone marrow (Bm).
Representative data from 2 independent experiments with 14 mice total.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10875 ARTICLE
NATURE COMMUNICATIONS | 7:10875 | DOI: 10.1038/ncomms10875 | www.nature.com/naturecommunications 9
For immunofluorescence microscopy, sections were stained with FITC- or
Alexa Fluor 546-coupled 7G6 (anti-CD21/35, 1 mg ml 1), FITC-coupled A20
(anti-CD45.1, 0.25 mg ml 1), digoxygenin-conjugated OX-7 (anti-Thy-1.1,
0.25 mg ml 1), digoxygenin-conjugated GL7 (anti-GC B cells, 1 mg ml 1) or
hamster anti-Ki-67 (Abcam, 1:100), followed by Alexa Fluor 594-coupled
anti-hamster Ig (Invitrogen, 1:500). Signals were amplified with peroxidase-
conjugated anti-FITC followed by FITC-coupled tyramide (Invitrogen).
After inactivation of peroxidase, the second antibody was detected with
anti-digoxygenin-peroxidase (Roche, 1:300) and Alexa Fluor 647-coupled
tyramide. Nuclei were counterstained with DAPI. Images were captured on
an LSM 780 with ZEN2010 imaging software (Carl Zeiss).
B-cell receptor sequencing. Four FDC-positive and six negative infiltrates
(determined by CD21/35 staining on a consecutive section) were isolated from
frozen lung sections using an Arcturus Veritas laser capture microdissection
system. RNA was isolated using the Arcturus PicoPure RNA isolation kit. The
VH186.2 sequence of the transgenic B1-8i B-cell receptor was amplified from
cDNA using a universal primer in the signal peptide (50-GATGGAGCTGTATCA
TGCTCTTCTTGGCAG-30) and specific primers for the heavy chain of IgA
(50-CACTGGGTCACTTGACAGAGCTTGTG-30), IgG1 (50-GCTGCTCAGAGTG
TAGAGGTCAGACTGC-30) and IgM (50-TGAAGGAAATGGTGCTGGGC
AGG-30). PCR products were cloned into pJET1.2. Sequences from 144 single
clones were analysed for somatic hypermutation.
Statistical analysis. Experimental groups contained at least five animals
(randomly assigned), which routinely provides the statistical power to detect
biological significant differences in our experimental system. Data were analysed
using GraphPad Prism 5. No data exclusion criteria were used.
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